← Back to Search

Omega-3 Fatty Acids

Omega-3 fatty acids for Metabolic Syndrome

Phase < 1
Waitlist Available
Led By Pathmaja Paramsothy, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year, 2 years
Awards & highlights

Study Summary

The purpose of this study is to determine the effects of omega-3 fatty acids in the form of fish oil supplementation (approximately 2 grams per day) on the carotid intima-media (CIMT)progression (primary objective) and 2)(Secondary objective) lipid markers such as LDL, apo-B, and LDL buoyancy, on inflammatory burden as measured by CRP, on oxidative stress as measured by urinary isoprostanes, urine microalbumin/creatinine, and serum adiponectin a fat derived hormone in subjects with metabolic syndrome.

Eligible Conditions
  • Metabolic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year, 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year, 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Carotid IMT
Secondary outcome measures
Glucose
Insulin
Lipid (apolipoproteins and lipid parameters)
+4 more

Trial Design

1Treatment groups
Placebo Group
Group I: 1Placebo Group1 Intervention
Omega-3 fatty acid vs. placebo comparator

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,251 Total Patients Enrolled
8 Trials studying Metabolic Syndrome
638 Patients Enrolled for Metabolic Syndrome
PfizerIndustry Sponsor
4,567 Previous Clinical Trials
10,911,774 Total Patients Enrolled
9 Trials studying Metabolic Syndrome
1,153 Patients Enrolled for Metabolic Syndrome
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,479 Total Patients Enrolled
11 Trials studying Metabolic Syndrome
2,087 Patients Enrolled for Metabolic Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
Pathmaja Paramsothy 2006. "The Effects of Omega-3 Fatty Acids on Metabolic Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00350194.
All > Osteopenia
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top